FIELD: medicine.
SUBSTANCE: invention relates to the use of triptanthrin-6-oxime as a drug with neuroprotective activity.
EFFECT: effective neuroprotective activity exhibited by triptanthrin-6-oxime. The invention expands the arsenal of drugs with neuroprotective activity.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODELING FOCAL ISCHEMIC STROKE OF BRAIN | 2020 |
|
RU2756427C1 |
AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
NEUROPROTECTIVE MEANS, HAVING THE PROPERTIES OF ANTIOXIDANT AND NITRIC OXIDE DONATOR | 2016 |
|
RU2680526C1 |
METHOD FOR BRAIN NEUROPROTECTION IN SIMULATING PHOTOINDUCED ISCHEMIC STROKE | 2023 |
|
RU2816057C1 |
USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
AGENT WITH CARDIOPROTECTIVE ACTIVITY | 2019 |
|
RU2791641C2 |
METHOD FOR PREVENTIVE GENE THERAPY FOR SUPPRESSING NEURON DEATH IN ISCHEMIC BRAIN STROKE | 2020 |
|
RU2748940C2 |
METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
Authors
Dates
2023-08-01—Published
2019-04-30—Filed